%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Mabel Aoun, Sahar H. Koubar, Leony Antoun, Hani Tamim, Maha Makki, Dania Chelala
Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 10 0 R/Contents 11 0 R/TrimBox[0 0 612 792]>>
endobj
10 0 obj
[12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R]
endobj
12 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref004)>>
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref005)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref006)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref007)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref008)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref009)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref010)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref013)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref014)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref015)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref016)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref017)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185847.ref013)>>
endobj
26 0 obj
<>/Border[0 0 0]/A 27 0 R>>
endobj
27 0 obj
<>
endobj
11 0 obj
[28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R]
endobj
28 0 obj
<>stream
q
0.83 0.64 0.02 0 k
203.4142 680.315 m
208.1764 680.315 l
h
f*
294.2929 654.3496 m
299.0551 654.3496 l
h
f*
203.4142 602.3055 m
208.1764 602.3055 l
h
f*
210.3874 602.3055 m
215.1496 602.3055 l
h
f*
232.4409 576.3402 m
237.2031 576.3402 l
h
f*
239.4142 576.3402 m
244.1764 576.3402 l
h
f*
322.526 550.3181 m
327.2315 550.3181 l
h
f*
329.4992 550.3181 m
339.0236 550.3181 l
h
f*
344.1827 550.3181 m
353.7071 550.3181 l
h
f*
530.8724 524.2961 m
540.3969 524.2961 l
h
f*
266.2299 485.348 m
275.7543 485.348 l
h
f*
526.7339 472.3087 m
536.2583 472.3087 l
h
f*
538.4693 472.3087 m
547.9937 472.3087 l
h
f*
440.1638 433.3039 m
449.6882 433.3039 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(primary)Tj
3.4525 0 Td
(prevention,)Tj
4.8076 0 Td
(revealed)Tj
3.5262 0 Td
(a)Tj
0.652 0 Td
(reduced)Tj
3.4469 0 Td
(risk)Tj
1.7121 0 Td
(for)Tj
1.389 0 Td
(nonfatal)Tj
3.5206 0 Td
(myocardial)Tj
4.7055 0 Td
(infarction)Tj
4.1782 0 Td
(\(MI\))Tj
2.1317 0 Td
(but)Tj
1.5533 0 Td
(not)Tj
-35.0756 -1.3039 Td
(for)Tj
1.3832 0 Td
(nonfatal)Tj
3.5263 0 Td
(stroke.)Tj
2.9027 0 Td
(Furthermore,)Tj
5.6125 0 Td
(it)Tj
0.7881 0 Td
(showed)Tj
3.2485 0 Td
(no)Tj
1.2755 0 Td
(benefit)Tj
2.9764 0 Td
(for)Tj
1.389 0 Td
(all-cause)Tj
3.668 0 Td
(or)Tj
1.0941 0 Td
(cardiovascular)Tj
6.0038 0 Td
(mortality)Tj
-33.8681 -1.2982 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.5987 0 Td
(Along)Tj
2.6702 0 Td
(with)Tj
2.0012 0 Td
(this)Tj
1.6725 0 Td
(uncertainty)Tj
4.8132 0 Td
(of)Tj
1.0148 0 Td
(reducing)Tj
3.7757 0 Td
(mortality)Tj
3.9175 0 Td
(in)Tj
1.0374 0 Td
(some)Tj
2.3301 0 Td
(categories)Tj
4.1952 0 Td
(of)Tj
1.0148 0 Td
(patients,)Tj
3.5943 0 Td
(aspirin's)Tj
-33.6356 -1.2983 Td
(main)Tj
2.2903 0 Td
(complication)Tj
5.4765 0 Td
(is)Tj
0.8504 0 Td
(bleeding.)Tj
3.8494 0 Td
(The)Tj
1.7859 0 Td
(incidence)Tj
4.0705 0 Td
(of)Tj
1.0148 0 Td
(major)Tj
2.6078 0 Td
(bleeding)Tj
3.634 0 Td
(events)Tj
2.7269 0 Td
(seems)Tj
2.6079 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(five)Tj
1.6497 0 Td
(times)Tj
-34.7411 -1.2983 Td
(higher)Tj
2.8006 0 Td
(in)Tj
1.0374 0 Td
(aspirin)Tj
2.9877 0 Td
(users)Tj
2.2621 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
-7.8916 -1.3039 Td
(Extrapolating)Tj
5.6465 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.4683 0 Td
(general)Tj
3.1294 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.474 0 Td
(hemodialysis)Tj
5.4141 0 Td
(\(HD\))Tj
2.4038 0 Td
(population)Tj
4.5921 0 Td
(is)Tj
0.8447 0 Td
(debatable)Tj
4.0252 0 Td
(because)Tj
-33.4259 -1.2982 Td
(aspirin)Tj
2.9876 0 Td
(use)Tj
1.5307 0 Td
(in)Tj
1.0319 0 Td
(end-stage)Tj
4.0535 0 Td
(renal)Tj
2.245 0 Td
(disease)Tj
3.016 0 Td
(\(ESRD\))Tj
3.3052 0 Td
(patients)Tj
3.3676 0 Td
(may)Tj
1.9275 0 Td
(be)Tj
1.1509 0 Td
(further)Tj
3.0273 0 Td
(associated)Tj
4.2577 0 Td
(with)Tj
1.9955 0 Td
(major)Tj
-33.8964 -1.2983 Td
(bleeding)Tj
3.6283 0 Td
(events)Tj
2.7269 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(gastrointestinal)Tj
6.3496 0 Td
(bleeding)Tj
3.6283 0 Td
(\(GIB\))Tj
2.5341 0 Td
(and)Tj
1.7292 0 Td
(intracerebral)Tj
5.3404 0 Td
(hemorrhage)Tj
5.091 0 Td
(\(ICH\))Tj
-34.1062 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
2.3017 0 Td
(However,)Tj
4.0762 0 Td
(cardiovascular)Tj
6.0037 0 Td
(mortality)Tj
3.9175 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3732 0 Td
(on)Tj
1.2699 0 Td
(dialysis)Tj
3.1408 0 Td
(is)Tj
0.8503 0 Td
(10)Tj
1.1679 0 Td
(to)Tj
1.0261 0 Td
(20)Tj
1.1736 0 Td
(times)Tj
2.3867 0 Td
(higher)Tj
2.8063 0 Td
(than)Tj
2.0239 0 Td
(in)Tj
-36.5496 -1.2983 Td
(the)Tj
1.4683 0 Td
(general)Tj
3.1351 0 Td
(population)Tj
4.5864 0 Td
(and)Tj
1.7291 0 Td
(it)Tj
0.7881 0 Td
(is)Tj
0.8504 0 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(both)Tj
2.0579 0 Td
(traditional)Tj
4.4221 0 Td
(and)Tj
1.7291 0 Td
(non-traditional)Tj
6.3779 0 Td
(cardiovascular)Tj
5.9981 0 Td
(risk)Tj
-35.8637 -1.2983 Td
(factors)Tj
2.9026 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
2.3017 0 Td
(Consequently,)Tj
5.9527 0 Td
(oral)Tj
1.7802 0 Td
(antiplatelet)Tj
4.6545 0 Td
(agents)Tj
2.7495 0 Td
(\(aspirin)Tj
3.3279 0 Td
(or/and)Tj
2.9367 0 Td
(clopidogrel\))Tj
5.0626 0 Td
(are)Tj
1.4513 0 Td
(frequently)Tj
-33.1197 -1.3039 Td
(prescribed)Tj
4.4106 0 Td
(in)Tj
1.0375 0 Td
(this)Tj
1.6724 0 Td
(population)Tj
4.5921 0 Td
(but)Tj
1.5534 0 Td
(the)Tj
1.4683 0 Td
(evidence)Tj
3.7134 0 Td
(behind)Tj
3.0217 0 Td
(their)Tj
2.109 0 Td
(use)Tj
1.5307 0 Td
(is)Tj
0.8504 0 Td
(conflicting)Tj
4.5014 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(indica-)Tj
-33.6583 -1.2982 Td
(tions)Tj
2.1996 0 Td
(are)Tj
1.4514 0 Td
(still)Tj
1.6384 0 Td
(not)Tj
1.5703 0 Td
(well)Tj
1.8199 0 Td
(defined)Tj
3.2315 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
4.2462 0 Td
(Based)Tj
2.5455 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(2005)Tj
2.1203 0 Td
(KDOQI)Tj
3.464 0 Td
(Clinical)Tj
3.3165 0 Td
(Practice)Tj
3.4185 0 Td
(Guide-)Tj
-33.766 -1.2983 Td
(lines)Tj
2.0636 0 Td
(for)Tj
1.3889 0 Td
(Cardiovascular)Tj
6.2419 0 Td
(Disease)Tj
3.2258 0 Td
(in)Tj
1.0375 0 Td
(Dialysis)Tj
3.3448 0 Td
(Patients,)Tj
3.634 0 Td
(there)Tj
2.2677 0 Td
(were)Tj
2.1203 0 Td
(no)Tj
1.2756 0 Td
(sufficient)Tj
3.9118 0 Td
(trials)Tj
2.1997 0 Td
(in)Tj
1.0374 0 Td
(this)Tj
-33.749 -1.3039 Td
(population)Tj
4.5864 0 Td
(that)Tj
1.7801 0 Td
(can)Tj
1.6271 0 Td
(establish)Tj
3.6453 0 Td
(the)Tj
1.4684 0 Td
(safety)Tj
2.4831 0 Td
(and)Tj
1.7291 0 Td
(efficacy)Tj
3.2202 0 Td
(of)Tj
1.0148 0 Td
(aspirin)Tj
2.9877 0 Td
(except)Tj
2.7722 0 Td
(following)Tj
3.9798 0 Td
(MI)Tj
1.4514 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
-31.5494 -1.2983 Td
(There)Tj
2.5795 0 Td
(are)Tj
1.4513 0 Td
(also)Tj
1.7631 0 Td
(conflicting)Tj
4.5071 0 Td
(data)Tj
1.9105 0 Td
(about)Tj
2.4945 0 Td
(oral)Tj
1.7802 0 Td
(anticoagulant)Tj
5.6522 0 Td
(use)Tj
1.5307 0 Td
(in)Tj
1.0375 0 Td
(dialysis.)Tj
3.3618 0 Td
(Their)Tj
2.4208 0 Td
(indication)Tj
4.3087 0 Td
(for)Tj
-35.9941 -1.2982 Td
(stroke)Tj
2.6702 0 Td
(prevention)Tj
4.5807 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3619 0 Td
(with)Tj
1.9956 0 Td
(atrial)Tj
2.262 0 Td
(fibrillation)Tj
4.4674 0 Td
(is)Tj
0.8447 0 Td
(well)Tj
1.8142 0 Td
(recognized)Tj
4.5864 0 Td
(and)Tj
1.7234 0 Td
(approved)Tj
3.9685 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4684 0 Td
(gen-)Tj
-35.807 -1.2983 Td
(eral)Tj
1.6951 0 Td
(population)Tj
4.5864 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
2.0806 0 Td
(However)Tj
3.8494 0 Td
(in)Tj
1.0375 0 Td
(dialysis)Tj
3.1408 0 Td
(patients,)Tj
3.5886 0 Td
(they)Tj
1.9276 0 Td
(may)Tj
1.9275 0 Td
(be)Tj
1.1509 0 Td
(prescribed)Tj
4.4106 0 Td
(for)Tj
1.389 0 Td
(atrial)Tj
2.2677 0 Td
(fibrillation)Tj
-33.0517 -1.3039 Td
(or)Tj
1.0941 0 Td
(vascular)Tj
3.4753 0 Td
(access)Tj
2.6475 0 Td
(patency)Tj
3.3165 0 Td
(\(VAP\))Tj
2.8403 0 Td
(but)Tj
1.5534 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6576 0 Td
(high)Tj
2.0069 0 Td
(risk)Tj
1.7121 0 Td
(of)Tj
1.0148 0 Td
(bleeding)Tj
3.6284 0 Td
(or)Tj
1.0998 0 Td
(calciphylaxis)Tj
5.2894 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
-31.1355 -1.2983 Td
(Obviously,)Tj
4.5184 0 Td
(until)Tj
2.1089 0 Td
(now,)Tj
2.1884 0 Td
(there)Tj
2.262 0 Td
(is)Tj
0.8504 0 Td
(no)Tj
1.2756 0 Td
(general)Tj
3.1294 0 Td
(agreement)Tj
4.4277 0 Td
(concerning)Tj
4.7451 0 Td
(the)Tj
1.4741 0 Td
(prescription)Tj
5.0909 0 Td
(of)Tj
1.0148 0 Td
(antith-)Tj
-34.2819 -1.2983 Td
(rombotic)Tj
3.9174 0 Td
(agents)Tj
2.7553 0 Td
(especially)Tj
4.0138 0 Td
(aspirin)Tj
2.9877 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(HD)Tj
1.7235 0 Td
(population.)Tj
4.8132 0 Td
(It)Tj
0.8617 0 Td
(is)Tj
0.8447 0 Td
(not)Tj
1.5761 0 Td
(clear)Tj
2.1203 0 Td
(yet)Tj
1.3946 0 Td
(why)Tj
1.8879 0 Td
(they)Tj
1.9218 0 Td
(cause)Tj
-33.3238 -1.3039 Td
(more)Tj
2.3414 0 Td
(bleeding)Tj
3.6283 0 Td
(in)Tj
1.0374 0 Td
(some)Tj
2.3301 0 Td
(patients)Tj
3.3676 0 Td
(and)Tj
1.7291 0 Td
(are)Tj
1.4513 0 Td
(beneficial)Tj
4.0479 0 Td
(in)Tj
1.0318 0 Td
(others)Tj
2.7099 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.0749 0 Td
(The)Tj
1.7858 0 Td
(present)Tj
3.1635 0 Td
(paper)Tj
2.4831 0 Td
(seeks)Tj
2.2847 0 Td
(to)Tj
-35.4668 -1.2982 Td
(understand)Tj
4.7848 0 Td
(the)Tj
1.474 0 Td
(factors)Tj
2.9027 0 Td
(that)Tj
1.7744 0 Td
(may)Tj
1.9333 0 Td
(trigger)Tj
2.8799 0 Td
(bleeding)Tj
3.6284 0 Td
(in)Tj
1.0374 0 Td
(HD)Tj
1.7235 0 Td
(patients)Tj
3.3675 0 Td
(treated)Tj
2.9934 0 Td
(with)Tj
2.0012 0 Td
(antithrombotic)Tj
-30.5005 -1.2983 Td
(agents.)Tj
2.9763 0 Td
(It)Tj
0.8561 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2018 0 Td
(observational)Tj
5.5786 0 Td
(study)Tj
2.3867 0 Td
(divided)Tj
3.2202 0 Td
(into)Tj
1.8368 0 Td
(two)Tj
1.7121 0 Td
(phases:)Tj
3.0671 0 Td
(phase)Tj
2.4831 0 Td
(one)Tj
1.7008 0 Td
(where)Tj
2.6532 0 Td
(aspirin)Tj
2.9821 0 Td
(was)Tj
1.7007 0 Td
(given)Tj
-35.206 -1.3039 Td
(to)Tj
1.0261 0 Td
(patients)Tj
3.3675 0 Td
(as)Tj
1.0148 0 Td
(per)Tj
1.5307 0 Td
(their)Tj
2.109 0 Td
(cardiologists')Tj
5.4708 0 Td
(recommendation)Tj
7.1376 0 Td
(and)Tj
1.7291 0 Td
(phase)Tj
2.4832 0 Td
(two)Tj
1.7121 0 Td
(where)Tj
2.6475 0 Td
(aspirin)Tj
2.9877 0 Td
(was)Tj
1.7008 0 Td
(no)Tj
-34.9169 -1.2983 Td
(more)Tj
2.3414 0 Td
(prescribed)Tj
4.4106 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6577 0 Td
(primary)Tj
3.4525 0 Td
(prevention)Tj
4.5808 0 Td
(and)Tj
1.7291 0 Td
(mostly)Tj
2.9084 0 Td
(avoided)Tj
3.3618 0 Td
(in)Tj
1.0375 0 Td
(severely)Tj
3.3732 0 Td
(hypertensive)Tj
5.2951 0 Td
(patients.)Tj
-34.1629 -1.2983 Td
(The)Tj
1.7801 0 Td
(objective)Tj
3.7814 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6724 0 Td
(study)Tj
2.3924 0 Td
(is)Tj
0.8504 0 Td
(to)Tj
1.0205 0 Td
(find)Tj
1.8538 0 Td
(out)Tj
1.5534 0 Td
(whether)Tj
3.4753 0 Td
(minimizing)Tj
4.9039 0 Td
(aspirin)Tj
2.9877 0 Td
(use)Tj
1.5307 0 Td
(in)Tj
1.0375 0 Td
(hemodialysis)Tj
-29.8543 -1.2982 Td
(patients)Tj
3.3675 0 Td
(would)Tj
2.7099 0 Td
(reduce)Tj
2.9197 0 Td
(bleeding)Tj
3.6283 0 Td
(events)Tj
2.7326 0 Td
(without)Tj
3.3278 0 Td
(affecting)Tj
3.6567 0 Td
(cardiovascular)Tj
6.0037 0 Td
(mortality.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 313.0015 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Study)Tj
2.7543 0 Td
(design,)Tj
3.4016 0 Td
(setting)Tj
3.1323 0 Td
(and)Tj
1.8614 0 Td
(participants)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 278.022 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(This)Tj
1.9842 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2019 0 Td
(observational)Tj
5.5785 0 Td
(before-and-after)Tj
6.7691 0 Td
(study)Tj
2.3868 0 Td
(\(quality-assurance)Tj
7.5287 0 Td
(study\))Tj
2.7326 0 Td
(where)Tj
2.6476 0 Td
(the)Tj
1.474 0 Td
(interven-)Tj
-33.1538 -1.3039 Td
(tion)Tj
1.8425 0 Td
(was)Tj
1.6951 0 Td
(minimizing)Tj
4.9039 0 Td
(aspirin)Tj
2.9877 0 Td
(use.)Tj
1.7574 0 Td
(All)Tj
1.3947 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
2.0013 0 Td
(ESRD)Tj
2.6192 0 Td
(undergoing)Tj
4.8755 0 Td
(chronic)Tj
3.2882 0 Td
(HD)Tj
1.7234 0 Td
(in)Tj
1.0318 0 Td
(Saint-)Tj
-33.4882 -1.2982 Td
(Georges)Tj
3.4865 0 Td
(Hospital)Tj
3.617 0 Td
(dialysis)Tj
3.1408 0 Td
(unit,)Tj
2.0863 0 Td
(between)Tj
3.5263 0 Td
(January)Tj
3.3221 0 Td
(2005)Tj
2.1203 0 Td
(and)Tj
1.7292 0 Td
(December)Tj
4.3483 0 Td
(2015,)Tj
2.3527 0 Td
(were)Tj
2.1203 0 Td
(included)Tj
3.7134 0 Td
(in)Tj
-35.5632 -1.2983 Td
(this)Tj
1.6724 0 Td
(study.)Tj
-0.4762 -1.3039 Td
(The)Tj
1.7858 0 Td
(study)Tj
2.3867 0 Td
(was)Tj
1.7008 0 Td
(divided)Tj
3.2145 0 Td
(into)Tj
1.8425 0 Td
(two)Tj
1.7064 0 Td
(phases:)Tj
3.0728 0 Td
(1-phase)Tj
3.3108 0 Td
(one)Tj
1.6951 0 Td
(\(before)Tj
3.0841 0 Td
(intervention\))Tj
5.5162 0 Td
(between)Tj
3.5263 0 Td
(January)Tj
-34.0382 -1.2983 Td
(2005)Tj
2.1203 0 Td
(and)Tj
1.7291 0 Td
(December)Tj
4.3483 0 Td
(2011,)Tj
2.3471 0 Td
(2-)Tj
1.0488 0 Td
(phase)Tj
2.4831 0 Td
(two)Tj
1.7121 0 Td
(\(after)Tj
2.3754 0 Td
(intervention\))Tj
5.5162 0 Td
(between)Tj
3.5263 0 Td
(January)Tj
3.3222 0 Td
(2012)Tj
2.1203 0 Td
(and)Tj
1.7291 0 Td
(Decem-)Tj
-34.3783 -1.2982 Td
(ber)Tj
1.5193 0 Td
(2015.)Tj
-0.3231 -1.304 Td
(The)Tj
1.7858 0 Td
(reason)Tj
2.863 0 Td
(for)Tj
1.3889 0 Td
(this)Tj
1.6725 0 Td
(study)Tj
2.3924 0 Td
(design)Tj
2.8119 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.4741 0 Td
(new)Tj
1.8708 0 Td
(policy)Tj
2.6362 0 Td
(that)Tj
1.7802 0 Td
(was)Tj
1.7007 0 Td
(introduced)Tj
4.6432 0 Td
(at)Tj
0.9524 0 Td
(our)Tj
1.6214 0 Td
(center)Tj
2.7099 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
-35.2967 -1.2982 Td
(end)Tj
1.7177 0 Td
(of)Tj
1.0148 0 Td
(2011,)Tj
2.3471 0 Td
(concerning)Tj
4.7508 0 Td
(antithrombotic)Tj
6.2929 0 Td
(agents')Tj
2.965 0 Td
(prescription,)Tj
5.3178 0 Td
(following)Tj
3.9798 0 Td
(several)Tj
2.9367 0 Td
(episodes)Tj
3.6056 0 Td
(of)Tj
-34.9282 -1.2983 Td
(ICH.)Tj
2.2166 0 Td
(In)Tj
1.1055 0 Td
(phase)Tj
2.4832 0 Td
(two,)Tj
1.9389 0 Td
(we)Tj
1.3266 0 Td
(stopped)Tj
3.3732 0 Td
(prescribing)Tj
4.7395 0 Td
(aspirin)Tj
2.9877 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(primary)Tj
3.4583 0 Td
(prevention.)Tj
4.8018 0 Td
(We)Tj
1.6101 0 Td
(allowed)Tj
3.2882 0 Td
(anti-)Tj
-34.9963 -1.2983 Td
(platelet)Tj
3.101 0 Td
(agents)Tj
2.7496 0 Td
(for)Tj
1.3833 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9955 0 Td
(previous)Tj
3.6454 0 Td
(myocardial)Tj
4.7054 0 Td
(infarction,)Tj
4.3937 0 Td
(coronary)Tj
3.8324 0 Td
(stents)Tj
2.5115 0 Td
(and/or)Tj
2.9367 0 Td
(periph-)Tj
-34.6221 -1.3039 Td
(eral)Tj
1.6951 0 Td
(artery)Tj
2.5738 0 Td
(disease.)Tj
3.2428 0 Td
(As)Tj
1.2643 0 Td
(a)Tj
0.6519 0 Td
(secondary)Tj
4.2746 0 Td
(prevention,)Tj
4.8019 0 Td
(aspirin)Tj
2.9877 0 Td
(was)Tj
1.7008 0 Td
(prescribed)Tj
4.4107 0 Td
(on)Tj
1.2755 0 Td
(a)Tj
0.652 0 Td
(daily)Tj
2.1543 0 Td
(basis)Tj
2.1487 0 Td
(if)Tj
0.7767 0 Td
(blood)Tj
-34.6108 -1.2982 Td
(pressure)Tj
3.5773 0 Td
(was)Tj
1.6951 0 Td
(controlled)Tj
4.3199 0 Td
(or)Tj
1.0999 0 Td
(on)Tj
1.2755 0 Td
(alternate)Tj
3.6964 0 Td
(day)Tj
1.6384 0 Td
(basis)Tj
2.1487 0 Td
(or)Tj
1.0998 0 Td
(replaced)Tj
3.583 0 Td
(by)Tj
1.1848 0 Td
(clopidogrel)Tj
4.7225 0 Td
(if)Tj
0.7767 0 Td
(they)Tj
1.9219 0 Td
(had)Tj
1.7064 0 Td
(severe)Tj
-34.4463 -1.2983 Td
(uncontrolled)Tj
5.3971 0 Td
(hypertension.)Tj
5.6919 0 Td
(Oral)Tj
2.0183 0 Td
(anticoagulants)Tj
6.015 0 Td
(were)Tj
2.1204 0 Td
(prescribed)Tj
4.4106 0 Td
(in)Tj
1.0375 0 Td
(any)Tj
1.6554 0 Td
(case)Tj
1.8652 0 Td
(of)Tj
1.0148 0 Td
(heart)Tj
2.2734 0 Td
(valve)Tj
-33.4996 -1.3039 Td
(replacement,)Tj
5.3744 0 Td
(atrial)Tj
2.2677 0 Td
(fibrillation)Tj
4.4674 0 Td
(or)Tj
1.0998 0 Td
(a)Tj
0.6576 0 Td
(previous)Tj
3.6454 0 Td
(vascular)Tj
3.4752 0 Td
(access)Tj
2.6476 0 Td
(thrombosis.)Tj
4.9719 0 Td
(All)Tj
1.3947 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(dia-)Tj
-35.4895 -1.2983 Td
(lyzed)Tj
2.2847 0 Td
(three)Tj
2.262 0 Td
(times)Tj
2.3924 0 Td
(per)Tj
1.5307 0 Td
(week.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 445.3795 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Antithrom)Tj
4.2094 0 Td
(botic)Tj
2.2961 0 Td
(agents)Tj
3.1678 0 Td
(in)Tj
0.9779 0 Td
(hemodia)Tj
3.763 0 Td
(lysis)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01858)Tj
4.089 0 Td
(47)Tj
0 g
2.0906 0 Td
(October)Tj
3.7276 0 Td
(2,)Tj
1.0417 0 Td
(2017)Tj
34.1365 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
BT
66.402 0 Td
(12)Tj
ET
Q
endstream
endobj
43 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 47 0 R/Contents 48 0 R/TrimBox[0 0 612 792]>>
endobj
44 0 obj
<>
endobj
49 0 obj
<>
endobj
50 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /TeX_CM_Maths_Italic def
/FontType 1 def
/FontBBox {-31 -239 1041 750} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (TeX_CM_Maths_Italic) readonly def
/BaseFontName (TeX_CM_Maths_Italic) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 0 /C0 put
dup 1 /C1 put
dup 2 /C2 put
dup 3 /C3 put
dup 4 /C4 put
dup 5 /C5 put
dup 6 /C6 put
dup 7 /C7 put
dup 8 /C8 put
dup 9 /C9 put
dup 10 /C10 put
dup 11 /C11 put
dup 12 /C12 put
dup 13 /C13 put
dup 14 /C14 put
dup 15 /C15 put
dup 16 /C16 put
dup 17 /C17 put
dup 18 /C18 put
dup 19 /C19 put
dup 20 /C20 put
dup 21 /C21 put
dup 22 /C22 put
dup 23 /C23 put
dup 24 /C24 put
dup 25 /C25 put
dup 26 /C26 put
dup 27 /C27 put
dup 28 /C28 put
dup 29 /C29 put
dup 30 /C30 put
dup 31 /C31 put
dup 32 /space put
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 48 /zero put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 57 /nine put
dup 58 /colon put
dup 59 /semicolon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 95 /underscore put
dup 96 /quoteleft put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
dup 127 /Euro put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤.vA2*Sr 2@Y0}Rcx,TX|ZP
;o<[1?
T<=qo:-62/]8~i wX?wJ`lLkI@EjYׅq5ڧHtvc6i 0M]YUN;M]ť0]z[{s1uO[6be#9k~d/YpMA.=뤎P\|W#?W$iz81ZL
Ңri^?WP]X A.@
z[
75y6k .U*3}hA\t&HW!Q
=+Г A 5